HOUSTON, TX--(Marketwired - May 11, 2015) - Nobilis Health Corp. (
Nobilis will acquire the entire hospital for the assumption of $5.5 Million in equipment leases and $7.0 Million in bank debt. No cash will be exchanged in the transaction.
"Our surgical center in Dallas is near capacity and this acquisition continues the company's strategic plan for 2015 to acquire additional in-network hospital capacity for our providers, patients and branded procedures," said Chris Lloyd, Nobilis' CEO. "Located in Plano, TX, a fast growing suburb north of Dallas, this hospital extends Nobilis' footprint and adds another premier facility to our growing portfolio."
"Much like the First Street Hospital acquisition last year and the Victory Healthcare Houston Hospital acquisition last month, we expect this new Dallas area facility to have an immediate positive impact on the revenues as our case volumes continue to grow," stated Harry Fleming, Chairman. "Our financial and cash position continue to strengthen and we remain focused on organic growth, as well as evaluating a strong pipeline of highly accretive M&A opportunities."
About Nobilis Health Corp.
Nobilis utilizes innovative direct-to-patient marketing focused on a specified set of procedures that are performed at our centers by local physicians. We own and manage ambulatory and acute care facilities to deliver healthcare services. Nobilis owns and manages interests in ambulatory surgery centers and acute care hospitals in Houston, Dallas, and Scottsdale, Arizona. Nobilis also owns and manages interests in two imaging centers and one urgent care clinic in Houston.
Forward-looking statements
This news release may contain forward-looking statements (within the meaning of applicable securities laws) and financial outlooks relating to the business of Nobilis Health Corp. (the "Company") and the environment in which it operates. Forward-looking statements are identified by words such as "believe", "anticipate", "expect", "intend", "plan", "will", "may" and other similar expressions and may discuss future expectations, contain projections of future results of operations or of financial condition, or state other forward-looking information. These statements are based on the Company's expectations, estimates, forecasts and projections and while the Company considers these to be reasonable based on information currently available, they may prove to be incorrect. They are not guarantees of future performance and involve risks and uncertainties that are difficult to control or predict. These risks and uncertainties are discussed in the Company's regulatory filings available on the Company's web site at www.NobilisHealth.com, www.Sedar.com and in the risk factors described in the Company's Form 10-K for the fiscal year ended December 31, 2014, filed on April 2, 2015. There can be no assurance that forward-looking statements will prove to be accurate as actual outcomes and results may differ materially from those expressed in these forward-looking statements. Readers, therefore, should not place undue reliance on any such forward-looking statements. Further, a forward-looking statement speaks only as of the date on which such statement is made. Other than as required by law, the Company undertakes no obligation to publicly update any such statement or to reflect new information or the occurrence of future events or circumstances.